文献速递炎症性肠病

疾病活动度对炎症性肠病患者心理症状及生活质量的影响:SADD研究结果

The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study.
PubMed 文献 · Aliment Pharmacol Ther · 2021-09-29

该前瞻性研究纳入172例接受回结肠镜检查的成人IBD患者(CD 107例,UC 65例),评估客观疾病活动度与心理症状的关联。结果显示内镜评分、粪钙卫蛋白或C反应蛋白与抑郁、焦虑或压力评分均无显著关联(P均>0.05),而胃肠道症状与CD和UC患者的抑郁、焦虑及压力症状显著相关(P<0.05)。多因素分析中仅胃肠道症状与严重抑郁(OR 20.78 [6.71-92.37],P<0.001)和焦虑(OR 4.26 [1.70-12.25],P=0.004)相关。

要点

  • 客观疾病活动度(内镜、粪钙卫蛋白、CRP)与心理症状无显著关联。
  • 胃肠道症状与CD和UC患者的抑郁、焦虑及压力症状显著相关。
  • 临床应关注有活动性胃肠道症状的IBD患者潜在的心理疾病。

核心结论

  • IBD患者的客观疾病活动度指标与心理疾病症状无关联。
  • 临床医生应考虑有活动性胃肠道症状的IBD患者存在潜在心理疾病。

研究设计与样本

  • 前瞻性研究纳入172例接受回结肠镜检查的成人IBD患者,其中克罗恩病107例,溃疡性结肠炎65例。

主要发现

  • 内镜评分、粪钙卫蛋白或C反应蛋白与抑郁、焦虑或压力评分均无显著关联(P均>0.05)。
  • 胃肠道症状与CD和UC患者的抑郁、焦虑及压力症状显著相关(P<0.05)。
  • 多因素分析中仅胃肠道症状与严重抑郁(OR 20.78 [6.71-92.37],P<0.001)和焦虑(OR 4.26 [1.70-12.25],P=0.004)相关。
  • 抗TNF药物和皮质类固醇使用、严重抑郁、中重度压力、胃肠道症状及内镜下活动性IBD与生活质量降低相关(P<0.05)。
  • IBD病程较长预测生活质量改善(P<0.05)。

临床怎么用

  • 对IBD患者应评估胃肠道症状而非仅依赖客观疾病活动度来识别心理疾病风险。
  • 有活动性胃肠道症状的IBD患者需考虑筛查抑郁和焦虑等心理疾病。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Disease activity may be a risk factor for psychological illness in patients with inflammatory bowel disease (IBD). AIM: To correlate objective measures of disease activity with psychological symptoms. METHODS: Adult patients with IBD undergoing ileocolonoscopy were prospectively recruited. Demographic, psychological symptoms (depression, anxiety, stress), disease activity (symptoms, biomarkers, endoscopy), and quality of life (QoL) data were collected. One-way ANOVA and multivariable analyses examined the associations between disease activity and symptoms of psychological illness, and identified other predictors of mental illness and reduced QoL. RESULTS: A total of 172 patients were included, 107 with Crohn's disease (CD) and 65 with ulcerative colitis (UC). There was no significant association between objective disease activity (endoscopic scores, faecal calprotectin or C-reactive protein) and depression, anxiety or stress scores (P > 0.05 for all comparisons). Gastrointestinal symptoms were significantly associated with symptoms of depression, anxiety and stress in patients with CD and UC (P < 0.05). On multivariable analysis, only gastrointestinal symptoms were associated with severe symptoms of depression (OR 20.78 [6.71-92.37], P < 0.001) and anxiety (OR 4.26 [1.70-12.25], P = 0.004). Anti-TNF and corticosteroid use, the presence of severe depressive, moderate-severe stress and gastrointestinal symptoms, and endoscopically active IBD were associated with a reduced QoL (P < 0.05). Longer duration of IBD predicted an improved QoL (P < 0.05). CONCLUSIONS: Objective measures of disease activity are not associated with symptoms of psychological illness in patients with IBD. Clinicians should consider underlying mental illness in patients with IBD with active gastrointestinal symptoms.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Mules TC, Swaminathan A, Hirschfeld E, et al. The impact of disease activity on psychological symptoms and quality of life in patients with inflammatory bowel disease-results from the Stress, Anxiety and Depression with Disease Activity (SADD) Study. Aliment Pharmacol Ther. 2021. PMID: 34587655. doi:10.1111/apt.16616

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。